Wang Yaru

Wang Yaru is currently a Student Consultant at Merck, focusing on quantitative market research regarding HPV vaccine gender equity in the Asia-Pacific region since July 2022. In addition, Wang holds the position of Vice President of the NTU Risk Management Society at Nanyang Business School and serves as a Program Intern at Big Idea Ventures, contributing to the New Protein Fund that invests in the alternative protein ecosystem. Previous experience includes internships at Alpha Consulting Engineers, Inc. and Science Centre Singapore. Wang is pursuing a degree at Nanyang Technological University Singapore, with prior education from Hwa Chong Institution and Nanyang Girls' High School, where foundational skills in science and mathematics were developed.